Literature DB >> 23519764

Functional protective effects of long-term memantine treatment in the DBA/2J mouse.

Jenny Atorf1, Michael Scholz, Fabian Garreis, Julia Lehmann, Lars Bräuer, Jan Kremers.   

Abstract

PURPOSE: To analyse the effects of long-term memantine treatment on the retinal physiology and morphology of DBA/2J mice.
METHODS: DBA/2J (D2J) mice received i.p. injections of the NMDA receptor antagonist memantine, which protects neurons from abnormally elevated glutamate levels, twice a day over a period of 7 months. At the age of 2, 6 and 10 months, the intraocular pressure (IOP) and electroretinograms (ERGs) were measured in all treated D2J mice, in untreated D2J controls and in C57Bl/6 (B6) wild-type mice. After the last measurement at the age of 10 months, the mice were killed and the retinae and the optic nerves were analysed morphologically.
RESULTS: The IOP increased with age in both D2J and B6 mice with a larger increase in the D2J strain. IOPs were not influenced by memantine treatment. The response amplitude of the scotopic flash ERG decreased with age in the D2J strain. This amplitude decrease, particularly that of the b-wave, was smaller in treated D2J mice. The retinae of treated D2J mice exhibited less peripheral degeneration of cone photoreceptors, and optic nerve neuropathy was less frequent.
CONCLUSIONS: Application of the NMDA receptor antagonist memantine diminished retinal neurodegeneration in the D2J mice and had a protective effect on the b-wave amplitude of the scotopic flash ERG. This protection may occur secondarily as memantine primarily acts on retinal ganglion cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23519764     DOI: 10.1007/s10633-013-9380-3

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  52 in total

1.  The toxic effect of sodium L-glutamate on the inner layers of the retina.

Authors:  D R LUCAS; J P NEWHOUSE
Journal:  AMA Arch Ophthalmol       Date:  1957-08

2.  Age-related alterations in neurons of the mouse retina.

Authors:  Melanie A Samuel; Yifeng Zhang; Markus Meister; Joshua R Sanes
Journal:  J Neurosci       Date:  2011-11-02       Impact factor: 6.167

3.  Missing optomotor head-turning reflex in the DBA/2J mouse.

Authors:  Peter Barabas; Wei Huang; Hui Chen; Christopher L Koehler; Gareth Howell; Simon W M John; Ning Tian; René C Rentería; David Krizaj
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-29       Impact factor: 4.799

Review 4.  Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide.

Authors:  S A Lipton
Journal:  Trends Neurosci       Date:  1993-12       Impact factor: 13.837

5.  [Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study].

Authors:  E Schneider; P A Fischer; R Clemens; F Balzereit; E W Fünfgeld; H J Haase
Journal:  Dtsch Med Wochenschr       Date:  1984-06-22       Impact factor: 0.628

6.  Method for the noninvasive measurement of intraocular pressure in mice.

Authors:  John Danias; Antti I Kontiola; Theodoros Filippopoulos; Thom Mittag
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

7.  Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma.

Authors:  Maher Saleh; Mahesh Nagaraju; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

8.  Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina.

Authors:  Won-Kyu Ju; Keun-Young Kim; Mila Angert; Karen X Duong-Polk; James D Lindsey; Mark H Ellisman; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

Review 9.  N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease.

Authors:  J T Greenamyre; C F O'Brien
Journal:  Arch Neurol       Date:  1991-09

10.  Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice.

Authors:  Tatjana C Jakobs; Richard T Libby; Yixin Ben; Simon W M John; Richard H Masland
Journal:  J Cell Biol       Date:  2005-10-24       Impact factor: 10.539

View more
  10 in total

1.  Mechanism for Altered Dark-Adapted Electroretinogram Responses in DBA/2J Mice Includes Pupil Dilation Deficits.

Authors:  Elizabeth R Bierlein; Jennie C Smith; Matthew J Van Hook
Journal:  Curr Eye Res       Date:  2022-03-04       Impact factor: 2.555

2.  Quantification of Changes in Visual Function During Disease Development in a Mouse Model of Pigmentary Glaucoma.

Authors:  Stephanie L Grillo; Christa L Montgomery; Heather M Johnson; Peter Koulen
Journal:  J Glaucoma       Date:  2018-09       Impact factor: 2.503

3.  Rod- and cone-driven responses in mice expressing human L-cone pigment.

Authors:  Tina I Tsai; Jenny Atorf; Maureen Neitz; Jay Neitz; Jan Kremers
Journal:  J Neurophysiol       Date:  2015-08-05       Impact factor: 2.714

4.  Rescue of retinal function by BDNF in a mouse model of glaucoma.

Authors:  Luciano Domenici; Nicola Origlia; Benedetto Falsini; Elisa Cerri; Davide Barloscio; Carlotta Fabiani; Marco Sansò; Luca Giovannini
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

5.  The BEACH Protein LRBA Promotes the Localization of the Heterotrimeric G-protein Golf to Olfactory Cilia.

Authors:  Stefan Kurtenbach; Andreas Gießl; Siv Strömberg; Jan Kremers; Jenny Atorf; Sebastian Rasche; Eva M Neuhaus; Denis Hervé; Johann Helmut Brandstätter; Esther Asan; Hanns Hatt; Manfred W Kilimann
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

6.  Mutation in Bmpr1b Leads to Optic Disc Coloboma and Ventral Retinal Gliosis in Mice.

Authors:  Xiaohe Yan; Jenny Atorf; David Ramos; Frank Thiele; Susanne Weber; Claudia Dalke; Minxuan Sun; Oliver Puk; Dian Michel; Helmut Fuchs; Matthias Klaften; Gerhard K H Przemeck; Sibylle Sabrautzki; Jack Favor; Jesús Ruberte; Jan Kremers; Martin Hrabe de Angelis; Jochen Graw
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

7.  Impact of cerebral hypoperfusion-reperfusion on optic nerve integrity and visual function in the DBA/2J mouse model of glaucoma.

Authors:  Stephan Alexander Fraenkl; Quentin Simon; Yeni Yucel; Neeru Gupta; Valéry V Wittwer; Beatrice E Frueh; Stefan A Tschanz
Journal:  BMJ Open Ophthalmol       Date:  2022-09

8.  Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma.

Authors:  Stephanie A Leopold; Ludwig F Zeilbeck; Gregor Weber; Roswitha Seitz; Michael R Bösl; Herbert Jägle; Rudolf Fuchshofer; Ernst R Tamm; Andreas Ohlmann
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

Review 9.  Recent advances in genetically modified animal models of glaucoma and their roles in drug repositioning.

Authors:  Chikako Harada; Atsuko Kimura; Xiaoli Guo; Kazuhiko Namekata; Takayuki Harada
Journal:  Br J Ophthalmol       Date:  2018-10-26       Impact factor: 4.638

Review 10.  Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications.

Authors:  Lin Fu; Sum Sum Kwok; Yau Kei Chan; Jimmy Shiu Ming Lai; Weihua Pan; Li Nie; Kendrick Co Shih
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.